Get started
Author

Elise Toussaint

Observed names: E Toussaint, E. Toussaint, Toussaint, Elise
Observed institutions: Inserm, Institut Jules Bordet, Institut de Cancérologie Strasbourg, Hôpitaux Universitaires de Strasbourg, Hôpital d'Hautepierre, Université de Strasbourg
ORCID: 0000-0002-4808-3322
Observed ORCID: 0000-0002-4808-3322
OpenAlex ID: A5018708339
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
2017 · G. Fossard, F. Broussais, et al. · Annals of Oncology · 141
PDF
Causes of fever in cancer patients (prospective study over 477 episodes)
2006 · E. Toussaint, E. Bahel-Ball, et al. · Supportive Care in Cancer · 79
Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
2011 · A. Hendlisz, V. Golfinopoulos, et al. · Annals of Oncology · 78
PDF
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi‐institutional retrospective study of 77 cases from the French Innovative Leukemia Organization ( FILO )
2017 · Eric Durot, Cécile Tomowiak, et al. · British Journal of Haematology · 55
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo
2019 · Cédric Schleiss, Wassila Ilias, et al. · Scientific Reports · 41
PDF
Clinical Pharmacokinetics of Methotrexate in Oncology
2017 · Dominique Levêque, Guillaume Becker, et al. · International Journal of Pharmacokinetics · 38
New pharmacological opportunities for the treatment of invasive mould diseases
2017 · Marie-Pierre Ledoux, Elise Toussaint, et al. · Journal of Antimicrobial Chemotherapy · 30
PDF
Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera
2019 · Sylvain Lescuyer, Marie-Pierre Ledoux, et al. · International Journal of Infectious Diseases · 28
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study
2021 · François Danion, Céline Duval, et al. · Clinical Microbiology and Infection · 25
PDF
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
2019 · Anne Quinquenel, Sophie Godet, et al. · American Journal of Hematology · 24
PDF
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
2020 · Eric Durot, Lukshe Kanagaratnam, et al. · Haematologica · 23
PDF
Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis
2018 · Julie Denis, Faezeh Forouzanfar, et al. · Journal of Molecular Diagnostics · 23
PDF
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
2022 · Eric Durot, Lukshe Kanagaratnam, et al. · Blood Advances · 12
PDF
Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?
2022 · Julien Labreuche, Deborah Assouan, et al. · Hematological Oncology · 8
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
2023 · Dipti Talaulikar, Cécile Tomowiak, et al. · Hematology/Oncology Clinics of North America · 7
Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case
2015 · A Ittel, C Hélias, et al. · Blood Cancer Journal · 6
PDF
Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome
2024 · Emmanuel Ledoult, Matthieu Groh, et al. · Haematologica · 5
PDF
Retrospective Analysis of 56 Cases of Transformed Waldenström Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO)
2016 · Eric Durot, Cecile Tomowiak, et al. · Blood · 5
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome
2025 · Romain Stammler, Alexandre Vallée, et al. · The Journal of Allergy and Clinical Immunology In Practice · 4
Autologous and Allogeneic Stem‐Cell Transplantation for Transformed Waldenström Macroglobulinemia
2024 · Eric Durot, Lukshe Kanagaratnam, et al. · American Journal of Hematology · 3
PDF
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study
2024 · David Morland, Lukshe Kanagaratnam, et al. · EJNMMI Research · 2
Mogamulizumab for Refractory CD3-CD4+ Lymphocytic-Variant Hypereosinophilic Syndrome
2023 · Emmanuel Ledoult, Matthieu Groh, et al. · Blood · 2
PDF
Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin
2023 · L. Veleanu, B. Tesson, et al. · Hematological Oncology · 2
PDF
Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment
2022 · Eric Durot, Cécile Tomowiak, et al. · Hemato · 2
PDF
Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib
2019 · Philippine Robert, Cédric Rossi, et al. · Blood · 2
Works count: 48
Citation count: 651
H-index: 12
I10-index: 13
Year
Topic
Type